These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31585318)

  • 1. Public policy, attitudes and willingness to pay for treatment of substance dependence in Iran.
    Ahmadian Moghaddam S; Mazyaki A; Razaghi EM
    Int J Drug Policy; 2019 Dec; 74():84-89. PubMed ID: 31585318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Public opinion of drug treatment policy: exploring the public's attitudes, knowledge, experience and willingness to pay for drug treatment strategies.
    Matheson C; Jaffray M; Ryan M; Bond CM; Fraser K; Kirk M; Liddell D
    Int J Drug Policy; 2014 May; 25(3):407-15. PubMed ID: 24332456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding co-payment for methadone maintenance services in Vietnam: the importance of addressing health and socioeconomic inequalities.
    Tran BX; Nguyen QL; Nguyen LH; Phan HTT; Le HT; Tran TD; Vu TTM; Latkin CA
    BMC Health Serv Res; 2017 Jul; 17(1):480. PubMed ID: 28701208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Willingness to pay for methadone maintenance treatment in Vietnamese epicentres of injection-drug-driven HIV infection.
    Tran BX
    Bull World Health Organ; 2013 Jul; 91(7):475-82. PubMed ID: 23825874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring the value of time for methadone maintenance clients: willingness to pay, willingness to accept, and the wage rate.
    Borisova NN; Goodman AC
    Health Econ; 2003 Apr; 12(4):323-34. PubMed ID: 12652518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of center-based compulsory rehabilitation compared to community-based voluntary methadone maintenance treatment in Hai Phong City, Vietnam.
    Vuong T; Shanahan M; Nguyen N; Le G; Ali R; Pham K; Vuong TTA; Dinh T; Ritter A
    Drug Alcohol Depend; 2016 Nov; 168():147-155. PubMed ID: 27664552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advertising representation, treatment menu and economic circulation of substance misuse treatment centers in Iran: a rapid survey based on newspaper advertisements.
    Rezaee S; Ekhtiari H
    Int J Drug Policy; 2014 May; 25(3):465-70. PubMed ID: 24873999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of injectable opioid treatment v. oral methadone for chronic heroin addiction.
    Byford S; Barrett B; Metrebian N; Groshkova T; Cary M; Charles V; Lintzeris N; Strang J
    Br J Psychiatry; 2013 Nov; 203(5):341-9. PubMed ID: 24029536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost of provision of opioid substitution therapy provision in Tijuana, Mexico.
    Burgos JL; Cepeda JA; Kahn JG; Mittal ML; Meza E; Lazos RRP; Vargas PC; Vickerman P; Strathdee SA; Martin NK
    Harm Reduct J; 2018 May; 15(1):28. PubMed ID: 29792191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights from a national survey into why substance abuse treatment units add prevention and outreach services.
    Wells R; Lemak CH; D'Aunno TA
    Subst Abuse Treat Prev Policy; 2006 Aug; 1():21. PubMed ID: 16887037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The political and scientific challenges in evaluating compulsory drug treatment centers in Southeast Asia.
    Vuong T; Nguyen N; Le G; Shanahan M; Ali R; Ritter A
    Harm Reduct J; 2017 Jan; 14(1):2. PubMed ID: 28077147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and cost-effectiveness of four treatment modalities for substance disorders: a propensity score analysis.
    Mojtabai R; Zivin JG
    Health Serv Res; 2003 Feb; 38(1 Pt 1):233-59. PubMed ID: 12650390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The trajectory of methadone maintenance treatment in Nepal.
    Ambekar A; Rao R; Pun A; Kumar S; Kishore K
    Int J Drug Policy; 2013 Nov; 24(6):e57-60. PubMed ID: 23845916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attitudes and beliefs of staff working in methadone maintenance clinics.
    Caplehorn JR; Irwig L; Saunders JB
    Subst Use Misuse; 1996 Mar; 31(4):437-52. PubMed ID: 8851811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Willingness to pay for drug abuse treatment: results from a contingent valuation study in Taiwan.
    Tang CH; Liu JT; Chang CW; Chang WY
    Health Policy; 2007 Jul; 82(2):251-62. PubMed ID: 17084480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The economic costs of jail-based methadone maintenance treatment.
    Horn BP; Li X; Mamun S; McCrady B; French MT
    Am J Drug Alcohol Abuse; 2018; 44(6):611-618. PubMed ID: 30024783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using the DATCAP and ASI to estimate the costs and benefits of residential addiction treatment in the State of Washington.
    French MT; Salomé HJ; Carney M
    Soc Sci Med; 2002 Dec; 55(12):2267-82. PubMed ID: 12409139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Social costs of robbery and the cost-effectiveness of substance abuse treatment.
    Basu A; Paltiel AD; Pollack HA
    Health Econ; 2008 Aug; 17(8):927-46. PubMed ID: 17992708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.